Provided by Tiger Trade Technology Pte. Ltd.

Recursion Pharmaceuticals, Inc.

3.14
-0.0299-0.94%
Volume:6.60M
Turnover:21.03M
Market Cap:1.66B
PE:-2.18
High:3.26
Open:3.10
Low:3.10
Close:3.17
52wk High:7.18
52wk Low:2.98
Shares:527.40M
Float Shares:415.00M
Volume Ratio:0.59
T/O Rate:1.59%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.4410
EPS(LYR):-1.4410
ROE:-59.54%
ROA:-27.72%
PB:1.46
PE(LYR):-2.18

Loading ...

Is It Time To Reassess Recursion Pharmaceuticals (RXRX) After Recent Share Price Weakness

Simply Wall St.
·
Jan 17

Nvidia Concept Stocks Rally. CoreWeave Up 8%; Recursion Up 4%; Nebius Up 3%; WeRide And Applied Digital Up 2%; SoundHound Up 1%

Tiger Newspress
·
Jan 12

Recursion Updates AI Drug Platform, Financial Outlook at JPM

TIPRANKS
·
Jan 12

Recursion Pharmaceuticals Files Initial Beneficial Ownership Statement for CSO David Hallett

Reuters
·
Jan 10

Recursion Pharmaceuticals Director Christopher Gibson Reports Sale of Common Shares

Reuters
·
Jan 08

Recursion Pharmaceuticals (RXRX): Assessing Valuation After New Activist Investor Filings With the SEC

Simply Wall St.
·
Jan 05

Getty Images, Torm, and More Stocks See Action From Activist Investors -- Barrons.com

Dow Jones
·
Jan 03

Recursion CFO Ben R. Taylor Reports Sale of Common Shares

Reuters
·
Dec 31, 2025

Chief R&D Commercial Officer Najat Khan Sells Recursion Pharmaceuticals Common Shares

Reuters
·
Dec 30, 2025

3 Small AI Plays to Buy for 2026

Benzinga_recent_news
·
Dec 27, 2025

Recursion Pharmaceuticals CEO Christopher Gibson Reports Sale of Common Shares

Reuters
·
Dec 20, 2025

Recursion Pharmaceuticals (RXRX): Valuation Check After Encouraging TUPELO Trial Data and Analyst Upgrades

Simply Wall St.
·
Dec 19, 2025

Nvidia-Linked Shares Shined. WhiteFiber Up 18%; CoreWeave Up 6%; Nebius And APLD Up 4%; Recursion, Core Scientific And Nano-X Up 3%

Tiger Newspress
·
Dec 19, 2025

Cathie Wood Dumps $11 Milllion Worth of Tesla Stock While Doubling Down on These Notable Crypto Plays

Benzinga
·
Dec 19, 2025

JPMorgan Upgrades Recursion Pharmaceuticals (RXRX.US) to "Overweight," Citing Blockbuster Potential for Core Asset REC-4881

Stock News
·
Dec 18, 2025

Cathie Wood's Big Crypto Bet: Ark Scoops up Bitmine, Coinbase and Bullish, Dumps This Amazon Rival

Benzinga
·
Dec 18, 2025

Recursion Pharmaceuticals Shares Rise After JPMorgan Upgrade

MT Newswires Live
·
Dec 18, 2025

Recursion Pharmaceuticals Rises 13.1% After JP Morgan Raises Co to 'Overweight' From 'Neutral'

THOMSON REUTERS
·
Dec 17, 2025

JPMorgan Upgrades Recursion Pharmaceuticals to Overweight From Neutral, Adjusts PT to $11 From $10

MT Newswires Live
·
Dec 17, 2025

Why Are Shares Of Recursion Pharmaceuticals Higher Today?

Benzinga_recent_news
·
Dec 08, 2025